Quark, GF Securities raising $500M fund

12:39 EDT 18 Oct 2016 | BioCentury

Canadian venture firm Quark Venture Inc. and Chinese investment bank GF Securities Co. Ltd. raised $100 million toward the planned $500 million Global Health Sciences Venture Fund. The Vancouver-based fund will invest globally in biotech and health sciences companies.

Earlier this month, the fund committed $30 million to MSI Methylation Sciences Inc. (Burnaby, B.C.), whose Strada (MS-195) is in Phase II testing to treat major depressive disorder (MDD).

Original Article: Quark, GF Securities raising $500M fund


More From BioPortfolio on "Quark, GF Securities raising $500M fund"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...